Viral vectors manufacturing

Duration: 5 days
Price: £3,750+VAT

Delivered in partnership with the Centre for Process Innovation, our Viral vectors manufacturing training course covers the production of viral vectors, their optimisation and scale-up.

The creation of this course has been funded by IUK through the ATSTN.

  • UKRI
  • atstn

    Training partners

  • NHC
  • Teesside University
  • cpi

Our unique training facility houses state-of- the-art equipment that provides delegates with the opportunity to gain hands-on practical training in complex bioprocessing procedures.

Learning outcomes:

  • Appreciate the expectations of the personnel working within a GMP facility
  • Understand the criteria use for selecting expression systems for different biotherapeutics
  • Describe how bioreactors work and the operating parameters which should be monitored and controlled
  • Evaluate CIP/SIP versus SU systems
  • Recall the scope, application, and operational strategies for downstream technologies
  • Recognise the importance of standard operating procedures in ensuring critical quality attributes are achieved and maintained
  • Appreciate the range and application of analytical techniques for supporting the manufacture of biotherapeutics and advanced therapies

Who should attend:

  • Scientists and engineers working in gene therapy and cell culture companies
  • Scientists, academics and engineers interested in production of viral vectors.

Course dates

Monday 5 – Friday 9 September 2022
Monday 27 - Friday 31 March 2023

For enquiries and details of the full agenda please email CPDNHC@tees.ac.uk

Book now

All our training courses are Covid safe and we have strict Risk Assessments in place to ensure our participants safety. Course fees are fully refundable should you need to cancel due to Covid. All participants are asked to have a negative Covid test prior to attending our courses.

View full list of courses